Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of INR 219.77 billion. The enterprise value is 197.70 billion.

Market Cap	219.77B
Enterprise Value	197.70B

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	Aug 21, 2024

Share Statistics

Pfizer has 45.75 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	n/a
Shares Outstanding	45.75M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	18.39%
Float	15.14M

Valuation Ratios

The trailing PE ratio is 35.57.

PE Ratio	35.57
Forward PE	n/a
PS Ratio	9.82
PB Ratio	5.86
P/TBV Ratio	6.88
P/FCF Ratio	54.76
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.82, with an EV/FCF ratio of 49.26.

EV / Earnings	32.00
EV / Sales	8.83
EV / EBITDA	27.82
EV / EBIT	30.33
EV / FCF	49.26

Financial Position

The company has a current ratio of 5.05, with a Debt / Equity ratio of 0.02.

Current Ratio	5.05
Quick Ratio	4.15
Debt / Equity	0.02
Debt / EBITDA	0.11
Debt / FCF	0.19
Interest Coverage	46.49

Financial Efficiency

Return on equity (ROE) is 17.59% and return on invested capital (ROIC) is 11.29%.

Return on Equity (ROE)	17.59%
Return on Assets (ROA)	9.63%
Return on Capital (ROIC)	11.29%
Revenue Per Employee	13.00M
Profits Per Employee	3.59M
Employee Count	1,721
Asset Turnover	0.53
Inventory Turnover	1.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.83% in the last 52 weeks. The beta is 0.25, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	+13.83%
50-Day Moving Average	5,251.97
200-Day Moving Average	5,056.54
Relative Strength Index (RSI)	33.22
Average Volume (20 Days)	38,699

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pfizer had revenue of INR 22.38 billion and earned 6.18 billion in profits. Earnings per share was 135.06.

Revenue	22.38B
Gross Profit	14.49B
Operating Income	6.52B
Pretax Income	8.38B
Net Income	6.18B
EBITDA	6.72B
EBIT	6.52B
Earnings Per Share (EPS)	135.06

Full Income Statement

Balance Sheet

The company has 22.81 billion in cash and 747.00 million in debt, giving a net cash position of 22.07 billion or 482.35 per share.

Cash & Cash Equivalents	22.81B
Total Debt	747.00M
Net Cash	22.07B
Net Cash Per Share	482.35
Equity (Book Value)	37.51B
Book Value Per Share	819.81
Working Capital	24.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.17 billion and capital expenditures -151.70 million, giving a free cash flow of 4.01 billion.

Operating Cash Flow	4.17B
Capital Expenditures	-151.70M
Free Cash Flow	4.01B
FCF Per Share	87.73

Full Cash Flow Statement

Margins

Gross margin is 64.75%, with operating and profit margins of 29.12% and 27.61%.

Gross Margin	64.75%
Operating Margin	29.12%
Pretax Margin	37.43%
Profit Margin	27.61%
EBITDA Margin	30.02%
EBIT Margin	29.12%
FCF Margin	17.93%

Dividends & Yields

This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.73%.

Dividend Per Share	35.00
Dividend Yield	0.73%
Dividend Growth (YoY)	-12.50%
Years of Dividend Growth	n/a
Payout Ratio	25.69%
Buyback Yield	0.00%
Shareholder Yield	0.73%
Earnings Yield	2.81%
FCF Yield	1.83%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a